Welcome to our dedicated page for Globavend Holdings SEC filings (Ticker: GVH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Globavend Holdings Limited (NASDAQ: GVH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. Globavend files reports with the U.S. Securities and Exchange Commission primarily on Form 20-F and Form 6-K, documenting its financial results, corporate actions, and material developments in its e-commerce logistics business.
Recent Form 6-K filings include unaudited condensed consolidated financial statements and Management’s Discussion and Analysis for the six months ended March 31, 2025, along with an earnings release. These filings give detail on revenue, cost of revenue, gross profit, operating expenses, and net income, as well as balance sheet items such as cash, accounts receivable, contract assets, and lease liabilities.
Other 6-K reports describe capital markets transactions, including a best-efforts public offering of units with Series A and Series B warrants, the terms of those warrants, and a later announcement that all outstanding Series B warrants with a zero price exercise option were fully exercised. Filings also cover a registered direct offering of ordinary shares or pre-funded warrants, with stated uses of proceeds for capital expenditures, operating capacity, working capital, warehouse purchases, overseas entity registration, and potential mergers and acquisitions.
Globavend’s filings further outline corporate governance and capital structure changes, such as the 1-for-200 reverse stock split of ordinary shares, the introduction of management shares with enhanced voting rights via a share subscription agreement, and shareholder approvals to increase authorized share capital and adopt new memorandum and articles of association. These documents explain the company’s dual-class share structure and controlled company status under Nasdaq rules.
On Stock Titan, Globavend’s SEC filings are updated as they appear on EDGAR, and AI-powered tools summarize key points from lengthy documents like 6-K exhibits and annual reports. Users can quickly see what each filing covers, from earnings and capital raises to governance changes, without reading every page, while still having direct access to the full SEC documents for deeper review.
Globavend Holdings has filed a 424B4 prospectus for a best-efforts offering of up to 21,739,130 Ordinary Units at $0.69 per unit. Each unit consists of one ordinary share, one Series A warrant, and one Series B warrant to purchase ordinary shares.
Key offering details:
- Series A Warrants: Exercise price equals 100% of unit price, with a 30-day reset feature (floor price $0.1395)
- Series B Warrants: Exercise price of $1.173 (170% of unit price) with a unique "zero exercise price" option
- Pre-Funded Units available for investors exceeding 4.99%/9.99% ownership thresholds
Notable risks include: significant potential dilution through Series B Warrants (up to 322,113,130 shares), no minimum offering amount required, and possible Nasdaq delisting concerns due to the zero-exercise price feature. The company recently regained Nasdaq compliance after falling below the $1.00 minimum bid requirement but faces ongoing listing risks due to potential price pressure from warrant exercises.
The SEC has declared Globavend Holdings' Form F-1 registration statement effective as of June 24, 2025, at 5:00 PM. This effectiveness notice (File No. 333-287533) marks a significant milestone for the company, indicating that the SEC has completed its review of Globavend's registration statement.
Form F-1 is the initial registration form for foreign companies planning to list securities in the U.S. markets. The effectiveness declaration allows Globavend Holdings to proceed with its planned securities offering, marking the company's transition toward becoming a publicly traded entity on a U.S. exchange.
This development represents a crucial step in Globavend's capital markets strategy, enabling the company to initiate its public offering process and potentially access U.S. capital markets for funding.